Migration and Invasion Enhancer 1 Is an NF-ĸB-Inducing Gene Enhancing the Cell Proliferation and Invasion Ability of Human Prostate Carcinoma Cells In Vitro and In Vivo

Metallothionein 3 Is a Hypoxia-Upregulated Oncogene Enhancing Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells

(2019) Ke-Hung Tsui et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer

(2019) Kyung Chan Park et al.   FREE RADICAL BIOLOGY AND MEDICINE

Interleukin-6 and prostate cancer: Current developments and unsolved questions

(2018) Zoran Culig et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells

(2018) Mulugeta M. Zegeye et al.   Cell Communication and Signaling

CRISPR deletion of MIEN1 in breast cancer cells

(2018) Timothy Van Treuren et al.   PLoS One

Migration and invasion enhancer 1 (MIEN1) is overexpressed in breast cancer and is a potential new therapeutic molecular target

(2017) H.-B. Zhao et al.   GENETICS AND MOLECULAR RESEARCH

Caffeic acid phenethyl ester upregulates N-myc downstream regulated gene 1 via ERK pathway to inhibit human oral cancer cell growth in vitro and in vivo

(2017) Li-Chuan Chung et al.   MOLECULAR NUTRITION & FOOD RESEARCH

The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion

(2017) Anup Sharma et al.   Molecular Oncology

miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition

(2017) Haipeng Ren et al.   OncoTargets and Therapy

BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells

(2017) Ke-Hung Tsui et al.   Cancer Medicine

MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-κB/MMP-9/VEGF pathways

(2016) Dongmei Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells

(2016) Ke-Hung Tsui et al.   CANCER LETTERS

MIEN1 drives breast tumor cell migration by regulating cytoskeletal-focal adhesion dynamics

(2016) Marilyne Kpetemey et al.   Oncotarget

MIEN1 is tightly regulated by SINE Alu methylation in its promoter

(2016) Smrithi Rajendiran et al.   Oncotarget

MIEN1 promotes oral cancer progression and implicates poor overall survival

(2015) Smrithi Rajendiran et al.   CANCER BIOLOGY & THERAPY

Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of NDRG1 promoter promotes proliferation and invasion of prostate cancer cells

(2015) YALIN LI et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression

(2015) Marilyne Kpetemey et al.   Molecular Cancer

Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells

(2015) Ke-Hung Tsui et al.   PROSTATE

MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1

(2014) Smrithi Rajendiran et al.   Molecular Cancer

Celastrol Blocks Interleukin-6 Gene Expression via Downregulation of NF-κB in Prostate Carcinoma Cells

(2014) Kun-Chun Chiang et al.   PLoS One

Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy

(2013) Bernard A. Fang et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells

(2013) K M Dixon et al.   BRITISH JOURNAL OF CANCER

The interaction between C35 and ΔNp73 promotes chemo-resistance in ovarian cancer cells

(2013) T H-Y Leung et al.   BRITISH JOURNAL OF CANCER

Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors

(2013) J. Sun et al.   CARCINOGENESIS

Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population

(2013) Yue Qiu et al.   GENE

Solution Structure of the Oncogenic MIEN1 Protein Reveals a Thioredoxin-Like Fold with a Redox-Active Motif

(2012) Chun-Hua Hsu et al.   PLoS One

Resonance assignments of human C35 (C17orf37) protein, a novel tumor biomarker

(2010) Chun-Jiun Yang et al.   Biomolecular NMR Assignments

A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk

(2010) E Katz et al.   BRITISH JOURNAL OF CANCER

Expression of interleukin-6 is downregulated by 17-(allylamino)-17-demethoxygeldanamycin in human prostatic carcinoma cells

(2009) Ke-hung Tsui et al.   ACTA PHARMACOLOGICA SINICA

Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells

(2009) S Dasgupta et al.   ONCOGENE

Interleukin (IL) 1β Induction of IL-6 Is Mediated by a Novel Phosphatidylinositol 3-Kinase-dependent AKT/IκB Kinase α Pathway Targeting Activator Protein-1

(2008) Catherine M. Cahill et al.   JOURNAL OF BIOLOGICAL CHEMISTRY